Press Room

There are 2 item(s) tagged with the keyword "Cardiovascular Risk".

1. Clinical Trial Seeks to Reduce Cardiovascular Risk in Adults with T1D

London, Ontario (March 2, 2012) − JDRF-funded researchers are currently enrolling adult patients with type 1 diabetes (T1D) in Canada for the REMOVAL (Reducing with MetfOrmin Vascular Adverse Lesions in T1D) study. The study will test whether metformin &ndash...


2. JDRF-Funded Study Seeks to Reduce Cardiovascular Risk in Adults with Type 1 Diabetes

New York, NY, December  13, 2011-JDRF-funded researchers have begun enrolling adult patients with type 1 diabetes (T1D) in the REMOVAL study, to test whether metformin-a drug commonly used to treat type 2 diabetes-could help prevent or reduce the risk of cardiovascular complications in people w...


Lets turn type one into type none